{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:58:31Z","timestamp":1787695111564,"version":"build-2784847793"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Patients with hematological malignancies undergo intensive treatment and prolonged hospitalization, thus having a variety of physical and psychosocial symptoms and worse quality of life (QOL). This study aimed to assess the QOL and investigate the symptoms of hospitalized hematological cancer patients. A cross-sectional study was conducted in the hematology clinics and day units of two general hospitals of Heraklion, Crete. Adult patients with hematological malignancy and an adequate understanding of the Greek language participated. A demographic questionnaire, the European Organization for Research and Treatment for Cancer quality assessment questionnaire (EORTC QLQ-C30), and the MD Anderson Symptom Inventory (MDASI) were used. The sample consisted of 120 patients\u201442.5% were women, with a mean age of 65.6 years. The mean time from diagnosis was 33 months. The global health status of QoL had an average value of 47.1. The highest levels of QOL were found in the subscale of cognitive function (72.8) and the lowest in the role function (46.1). For the EORTC QLQ-C30 symptoms scale, the lowest score was found in nausea-vomiting (11.0) and the highest in fatigue (59.1). In the MDASI, in part I (core symptoms), higher levels but also medium intensities were reported at fatigue (78.3%, mean 3.5), drowsiness (65.0, mean 3.3), and distress (65.8%, mean 2.8). In part II, enjoyment of life (85.8%, mean 5.1) had the highest, and relation with other people (67.5%, mean 3.7) had the lowest scores. The increase in the severity of the core symptoms (part I) was related to females (rho = 0.193, p &lt;0.05) and comorbidities (rho = 0.220, p &lt; 0.05). It was also associated with a significant decrease in all functional domains and increased fatigue (rho = 0.571, p &lt; 0.05) in the EORTC QLQ-C30 questionnaire. The increased global health status was related to males (rho = \u22120.185, p &lt; 0.05) and physical functioning with younger age (rho = \u22120.331, p &lt; 0.05), higher education (rho = 0.239, p &lt; 0.05), fewer months from diagnosis (rho = \u22120.199, p &lt; 0.05), and low comorbidity (rho = \u22120.209, p &lt; 0.05). Finally, multiple linear regression analysis revealed that the total average symptom score of the MDASI was the most significant factor influencing the global health status of the EORTC QLQ-C30 (\u03b2 = \u22124.91, p &lt; 0.001). The increased global health status of the EORTC QLQ C30 was not significantly related (p &gt; 0.05) to the social characteristics of the patients, such as education or employment, which requires further validation. The QoL of hematological cancer patients significantly decreases during treatments due to a considerable number of symptoms that must be taken into consideration for high-quality, individualized care.<\/jats:p>","DOI":"10.3390\/curroncol31110494","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:51:26Z","timestamp":1730109086000},"page":"6699-6710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Quality of Life and Symptoms of Hospitalized Hematological Cancer Patients"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-2585","authenticated-orcid":false,"given":"Theocharis I.","family":"Konstantinidis","sequence":"first","affiliation":[{"name":"Department of Nursing, Hellenic Mediterranean University, 71410 Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-3642","authenticated-orcid":false,"given":"Ioanna","family":"Tsatsou","sequence":"additional","affiliation":[{"name":"One Day Clinic, Hellenic Airforce General Hospital, 11523 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Tsagkaraki","sequence":"additional","affiliation":[{"name":"Department of Nursing, Venizeleio General Hospital of Heraklion, 71409 Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Chasouraki","sequence":"additional","affiliation":[{"name":"Department of Nursing, University General Hospital of Heraklion, 71500 Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Saridi","sequence":"additional","affiliation":[{"name":"Department of Nursing, University of Thessaly, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-8260","authenticated-orcid":false,"given":"Theodoula","family":"Adamakidou","sequence":"additional","affiliation":[{"name":"Department of Nursing, University of West Attica, 12243 Egaleo, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-443X","authenticated-orcid":false,"given":"Ourania","family":"Govina","sequence":"additional","affiliation":[{"name":"Department of Nursing, University of West Attica, 12243 Egaleo, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"WhoQol Group (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med., 28, 28551\u201328558.","DOI":"10.1017\/S0033291798006667"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0885-3924(94)90129-5","article-title":"Quality of life: Concepts and definition","volume":"9","author":"Cella","year":"1994","journal-title":"J. Pain Symptom Manag."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1310\/sci2003-167","article-title":"Definitions of quality of life: What has happened and how to move on","volume":"20","author":"Post","year":"2014","journal-title":"Top. Spinal Cord Inj. Rehabil."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-40187-9_10","article-title":"Quality of life in oncology","volume":"197","author":"Goerling","year":"2014","journal-title":"Psycho-Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1038\/bcj.2015.29","article-title":"Haematological cancer and quality of life: A systematic literature review","volume":"5","author":"Porro","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.critrevonc.2013.03.008","article-title":"Supportive care needs of hematological cancer survivors: A critical review of the literature","volume":"88","author":"Hall","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Herrmann, A., Mansfield, E., Tzelepis, F., Lynagh, M., and Hall, A. (2020). Use of the supportive care framework to explore haematological cancer survivors\u2019 unmet needs: A qualitative study. BMC Health Serv. Res., 20.","DOI":"10.1186\/s12913-020-05927-7"},{"key":"ref_8","first-page":"62","article-title":"Depression, anxiety and stress among patients with hematological malignancies and the association with quality of life: A cross-sectional study","volume":"93","author":"Papathanasiou","year":"2020","journal-title":"Med. Pharm. Rep."},{"key":"ref_9","first-page":"5","article-title":"Unmet Supportive Care Needs of Patients with Hematological Malignancies: A Systematic Review","volume":"15","author":"Tsatsou","year":"2020","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_10","first-page":"412","article-title":"Supportive care needs of advanced cancer patients. The nursing perspective","volume":"31","author":"Konstantinidis","year":"2014","journal-title":"Arch. Hell. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/a0037821","article-title":"Health-related quality of life measurement in oncology: Advances and opportunities","volume":"70","author":"Cella","year":"2015","journal-title":"Am. Psychol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline","volume":"33","author":"Basch","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_13","unstructured":"Apostolaki, E., Tsagkaraki, E., and Chasouraki, E. (2022). Evaluation of the Quality of Life and the Symptoms of Hospitalized Hematologically Patients. [Bachelor\u2019s Thesis, Hellenic Mediterranean University]. Available online: https:\/\/apothesis.lib.hmu.gr\/handle\/20.500.12688\/10174."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ijc.1439","article-title":"The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: Validity and reliability in a Hellenic sample","volume":"94","author":"Mystakidou","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000081318","article-title":"Anderson Symptom Inventory: Validation and utility in cancer patients","volume":"67","author":"Mystakidou","year":"2004","journal-title":"Oncology"},{"key":"ref_17","first-page":"1","article-title":"Health Related Quality of Life among Blood Cancer Patients in Pakistan: A Cross Sectional Survey","volume":"58","author":"Malik","year":"2021","journal-title":"Inquiry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.blre.2021.100851","article-title":"Targeting health-related quality of life in patients with myelodysplastic syndromes\u2013Current knowledge and lessons to be learned","volume":"50","author":"Oliva","year":"2021","journal-title":"Blood Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5505\/aot.2022.25991","article-title":"Quality of Life assessment with EORTC QLQ in patients with hodgkin lymphoma: Multicenter study","volume":"55","author":"Gemici","year":"2022","journal-title":"Acta Oncol. Turc."},{"key":"ref_20","first-page":"174","article-title":"Health Related Quality of Life in Patients with Onco-hematological Diseases","volume":"30","author":"Caocci","year":"2020","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1182\/blood-2014-03-558981","article-title":"Symptom burden in hematologic malignancies","volume":"123","author":"Charles","year":"2014","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jpainsymman.2010.12.008","article-title":"The symptom burden of patients with hematological malignancy: A cross-sectional observational study","volume":"42","author":"Manitta","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"ref_23","first-page":"117","article-title":"Quality of life among patients with hematological cancer in a Malaysian hospital","volume":"1","author":"Priscilla","year":"2011","journal-title":"Med. J. Malays."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.7314\/APJCP.2014.15.17.7153","article-title":"Symptoms and symptom clusters in non Hodgkin\u2019s lymphoma patients in Turkey","volume":"15","author":"Bolukbas","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00277-014-2139-4","article-title":"Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population","volume":"93","author":"Tanimukai","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood-2013-01-477687","article-title":"Measuring the symptom burden associated with the treatment of chronic myeloid leukemia","volume":"122","author":"Williams","year":"2013","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00520-021-06377-5","article-title":"Sleep problems and their interaction with physical activity and fatigue in hematological cancer patients during onset of high dose chemotherapy","volume":"30","author":"Castelli","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12762","DOI":"10.1111\/ecc.12762","article-title":"The relationship between pain, fatigue, sleep disorders and quality of life in adult patients with acute leukaemia: During the first year after diagnosis","volume":"27","author":"Miladinia","year":"2018","journal-title":"Eur. J. Cancer Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0277-9536(01)00043-0","article-title":"Sleep disturbance in cancer patients","volume":"54","author":"Davidson","year":"2002","journal-title":"Soc. Sci. Med."},{"key":"ref_30","first-page":"377","article-title":"Evaluation of the Side-Effects of Chemotherapy in Patients with Cancer","volume":"49","author":"Polikandrioti","year":"2010","journal-title":"Nosileftiki"},{"key":"ref_31","first-page":"336","article-title":"Assessment of Symptoms in Cancer Patients","volume":"55","author":"Alamanou","year":"2016","journal-title":"Nosileftiki"},{"key":"ref_32","first-page":"74","article-title":"Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy","volume":"23","author":"Musarezaie","year":"2014","journal-title":"J. Educ. Health Promot."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1182\/blood.V120.21.4709.4709","article-title":"Health-related quality of life in hematological malignancy patients in northwestern turkey","volume":"120","author":"Pamuk","year":"2012","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/ecc.13067","article-title":"Quality of life in survivors of adult haematological malignancy","volume":"28","author":"Immanuel","year":"2019","journal-title":"Eur. J. Cancer Care"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Howell, D.A., McCaughan, D., Smith, A.G., Patmore, R., and Roman, E. (2022). Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers\u2014A qualitative study from the UK\u2019s Haematological Malignancy Research Network. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263672"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1634\/theoncologist.2019-0348","article-title":"The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the \u201cReal-World\u201d: Results from the Population-Based PROFILES Registry","volume":"25","author":"Husson","year":"2020","journal-title":"Oncologist"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/annonc\/mds091","article-title":"Cultural beliefs and values in cancer patients","volume":"23","author":"Daher","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(04)01386-5","article-title":"Explanatory models of and attitudes towards cancer in different cultures","volume":"5","author":"Dein","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cncr.21251","article-title":"Closing the divide: Diverse populations and cancer survivorship","volume":"104","author":"Guidry","year":"2005","journal-title":"Cancer"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/494\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:21:58Z","timestamp":1760113318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["curroncol31110494"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31110494","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}